Therapeutic Area | MeSH |
---|---|
nutritional and metabolic diseases | D009750 |
Brand Name | Status | Last Update |
---|---|---|
25 person ansi | OTC monograph final | 2010-06-07 |
50 person ansi | OTC monograph final | 2010-06-07 |
adult infuvite multiple vitamins | New Drug Application | 2019-05-14 |
arc first aid emergency preparedness contains 167 pieces | OTC monograph final | 2010-06-07 |
aronamin gold | unapproved drug other | 2018-12-12 |
bacmin | unapproved drug other | 2014-05-02 |
bio no brain care (helps improve brain blood flow and body temperature, fermented garlic powder) | unapproved drug other | 2025-03-14 |
bio no more yeast infection (helps improve vaginal yeast infection, fermented cabbage powder) | unapproved drug other | 2025-03-14 |
biovita | unapproved drug other | 2019-01-14 |
body glove for men antibacterial hand sanitizer tea tree and vitamin e scented | OTC monograph not final | 2020-11-13 |
Code | Description |
---|---|
J2787 | Riboflavin 5'-phosphate, ophthalmic solution, up to 3 ml |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Colorectal neoplasms | D015179 | — | — | 67 | 206 | 94 | 6 | 9 | 349 |
Adenocarcinoma | D000230 | — | — | 53 | 103 | 39 | 1 | 1 | 172 |
Neoplasms | D009369 | — | C80 | 76 | 55 | 20 | 1 | 9 | 139 |
Keratoconus | D007640 | EFO_0004223 | H18.6 | 10 | 23 | 34 | 4 | 45 | 104 |
Stomach neoplasms | D013274 | EFO_0003897 | C16 | 20 | 59 | 15 | 2 | 7 | 91 |
Esophageal neoplasms | D004938 | — | C15 | 16 | 48 | 10 | 2 | 2 | 66 |
Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | 4 | 13 | 16 | 5 | 33 | 66 |
Lymphoma | D008223 | — | C85.9 | 22 | 38 | 11 | 2 | 1 | 65 |
Syndrome | D013577 | — | — | 14 | 17 | 8 | 7 | 27 | 65 |
Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 5 | 17 | 15 | 6 | 28 | 65 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 49 | 88 | 22 | — | 2 | 135 |
Leukemia | D007938 | — | C95 | 22 | 44 | 28 | — | 2 | 84 |
Rectal neoplasms | D012004 | — | — | 20 | 50 | 13 | — | 2 | 81 |
Carcinoma | D002277 | — | C80.0 | 29 | 43 | 18 | — | 2 | 74 |
Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 11 | 31 | 25 | — | 2 | 62 |
Colonic neoplasms | D003110 | — | C18 | 16 | 24 | 26 | — | 2 | 61 |
Lymphoid leukemia | D007945 | — | C91 | 11 | 29 | 23 | — | 2 | 58 |
Recurrence | D012008 | — | — | 19 | 23 | 5 | — | 4 | 46 |
Non-small-cell lung carcinoma | D002289 | — | — | 24 | 23 | 9 | — | — | 44 |
Lung neoplasms | D008175 | — | C34.90 | 12 | 20 | 9 | — | 2 | 34 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Breast neoplasms | D001943 | EFO_0003869 | C50 | 19 | 14 | — | — | 5 | 32 |
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 11 | 7 | — | — | 1 | 17 |
Cholangiocarcinoma | D018281 | — | C22.1 | 5 | 12 | — | — | 1 | 17 |
Aging | D000375 | GO_0007568 | R41.81 | 1 | 3 | — | — | 12 | 16 |
Depression | D003863 | — | F33.9 | 1 | 4 | — | — | 9 | 14 |
Myelodysplastic syndromes | D009190 | — | D46 | 10 | 6 | — | — | — | 13 |
Myeloid leukemia acute | D015470 | — | C92.0 | 11 | 4 | — | — | — | 13 |
Preleukemia | D011289 | — | — | 10 | 5 | — | — | — | 12 |
Gallbladder neoplasms | D005706 | EFO_0004606 | C23 | 5 | 7 | — | — | — | 11 |
Alzheimer disease | D000544 | EFO_0000249 | F03 | 5 | 7 | — | — | 2 | 11 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | 1 | — | — | — | 5 | 6 |
Blood pressure | D001794 | EFO_0004325 | — | 1 | — | — | — | 4 | 5 |
Constipation | D003248 | — | K59.0 | 1 | — | — | — | 4 | 5 |
Sleep apnea syndromes | D012891 | EFO_0003877 | G47.3 | 2 | — | — | — | 1 | 3 |
Abdominal obesity | D056128 | — | — | 1 | — | — | — | 2 | 3 |
Pharmacokinetics | D010599 | — | — | 2 | — | — | — | 1 | 3 |
Nutritional status | D009752 | — | — | 1 | — | — | — | 2 | 3 |
Biological availability | D001682 | — | — | 2 | — | — | — | 1 | 3 |
Obstructive lung diseases | D008173 | — | — | 1 | — | — | — | 2 | 3 |
Skin diseases | D012871 | — | L00-L99 | 2 | — | — | — | 1 | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Weight loss | D015431 | — | — | — | — | — | — | 6 | 6 |
Folic acid deficiency | D005494 | EFO_0001070 | E53.8 | — | — | — | — | 6 | 6 |
Open-angle glaucoma | D005902 | EFO_0004190 | H40.1 | — | — | — | — | 5 | 5 |
Alopecia areata | D000506 | EFO_0004192 | L63 | — | — | — | — | 5 | 5 |
Alopecia | D000505 | — | L64 | — | — | — | — | 5 | 5 |
Bone diseases | D001847 | — | M89.9 | — | — | — | — | 4 | 4 |
Bone fractures | D050723 | EFO_0003931 | T14.8 | — | — | — | — | 4 | 4 |
Menopause | D008593 | EFO_0003922 | N95 | — | — | — | — | 4 | 4 |
Exercise | D015444 | EFO_0000483 | — | — | — | — | — | 4 | 4 |
Dietary supplements | D019587 | — | — | — | — | — | — | 4 | 4 |
Drug common name | Riboflavin |
INN | riboflavin |
Description | Riboflavin is d-Ribitol in which the hydroxy group at position 5 is substituted by a 7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl moiety. It is a nutritional factor found in milk, eggs, malted barley, liver, kidney, heart, and leafy vegetables, but the richest natural source is yeast. The free form occurs only in the retina of the eye, in whey, and in urine; its principal forms in tissues and cells are as flavin mononucleotide and flavin-adenine dinucleotide. It has a role as a photosensitizing agent, a food colouring, an Escherichia coli metabolite, a mouse metabolite, a cofactor, a plant metabolite, a human urinary metabolite, an anti-inflammatory agent, a fundamental metabolite and an antioxidant. It is a vitamin B2 and a flavin. It is a conjugate acid of a riboflavin(1-). |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | Cc1cc2nc3c(=O)[nH]c(=O)nc-3n(C[C@H](O)[C@H](O)[C@H](O)CO)c2cc1C |
PDB | — |
CAS-ID | 83-88-5 |
RxCUI | — |
ChEMBL ID | CHEMBL1534 |
ChEBI ID | 17015 |
PubChem CID | 493570 |
DrugBank | DB00140 |
UNII ID | TLM2976OFR (ChemIDplus, GSRS) |